ACE2 and respiratory system disorder: Although COVID-19 is primarily regarded as a respiratory disease, systemic (extrapulmonary) manifestations are frequently observed, attributed to the widespread expression of ACE2 (angiotensin-converting enzyme 2), which may lead to multiorgan involvement.